Stephan Rietbrock
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management 4
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 6
-
- Atrial Fibrillation Management and Outcomes 6
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 6
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 4
-
- Analytical Methods in Pharmaceuticals 4
-
- Analytical Chemistry and Chromatography 3
-
- Parkinson's Disease Mechanisms and Treatments 3
-
- Pharmaceutical studies and practices 3
- Co-authors
- Carlos MartínezTjeerd van StaaUwe FuhrArlene M. GallagherLuke BamberAnja KatholingAlexander T. CohenM Zaigler
- Journals
- Antimicrobial Agents and Chemotherapy (1 paper)BMJ (1 paper)Journal of Bone and Mineral Research (1 paper)
- Partner nations
- GermanyUnited KingdomNetherlands
In The Last Decade
Stephan Rietbrock
38 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 127
- Internal Medicine 432
- Pharmacology 334
- Cardiology and Cardiovascular Medicine 659
- Pharmacology 381
- Oncology 438
Countries citing papers authored by Stephan Rietbrock
This map shows the geographic impact of Stephan Rietbrock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Rietbrock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Rietbrock more than expected).
Fields of papers citing papers by Stephan Rietbrock
This network shows the impact of papers produced by Stephan Rietbrock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Rietbrock. The network helps show where Stephan Rietbrock may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stephan Rietbrock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 34 | |
| 2 | 2016 | 190 | |
| 3 | 2016 | 128 | |
| 4 | 2014 | 142 | |
| 5 | 2013 | 72 | |
| 6 | 2009 | 23 | |
| 7 | 2008 | 179 | |
| 8 | 2008 | 161 | |
| 9 | 2008 | 26 | |
| 10 | 2008 | 3 | |
| 11 | 2007 | 16 | |
| 12 | 2005 | 185 | |
| 13 | 2003 | 76 | |
| 14 | 2002 | 7 | |
| 15 | 2000 | 15 | |
| 16 | 2000 | 109 | |
| 17 | 2000 | 33 | |
| 18 | 1999 | 28 | |
| 19 | 1995 | 35 | |
| 20 | 1992 | 6 |
About Stephan Rietbrock
Stephan Rietbrock is a scholar working on Internal Medicine, Pharmacology and Anesthesiology and Pain Medicine, having authored 38 papers that have together received 2.3k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (6 papers), Pharmacogenetics and Drug Metabolism (6 papers), Analytical Methods in Pharmaceuticals (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Analytical Chemistry and Chromatography (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Pharmaceutical studies and practices (3 papers). The work is most often cited by research in Internal Medicine (432 citations), Pharmacology (334 citations) and Cardiology and Cardiovascular Medicine (659 citations). Stephan Rietbrock has collaborated with scholars based in Germany, United Kingdom and Netherlands. Frequent co-authors include Carlos Martínez, Tjeerd van Staa, Uwe Fuhr, Arlene M. Gallagher, Luke Bamber, Anja Katholing, Alexander T. Cohen, M Zaigler, Jonathan Plumb and Emma Heeley. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, BMJ and Journal of Bone and Mineral Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.